Global Revascularization Devices Market Forecast, Trend Analysis And Competition Tracking - Market Insights: 2015 – 2031

Global Revascularization Devices Market Overview:

When people undergo bypass surgery, surgeons widen an artery with a balloon. The surgeon passes the graft-a tube of blood vessel tissue external to the body-through this newly created opening.

Next, they tie off the ends. Sometimes there are heart problems that make it difficult for the surgeon to use open-heart surgery to bypass clogged arteries.

One alternative is radial artery harvesting, where the surgeon removes a section of a healthy artery from your arm and attaches it to your heart.

A variety of devices can be used in the process of revascularization. Some devices are used to bypass blocked vessels, some are used to reduce plaque build-up in a vessel, and others are designed for the treatment of an aneurysm.

“The Revascularization Devices Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”

A heart bypass surgery, also known as a coronary artery bypass graft, is a surgical procedure used to bypass blocks in the coronary arteries.

A surgical incision is made in the chest, and the heart is moved out of the way to expose the blocked artery. The surgeon then removes any plaque formations that are blocking blood flow to the affected area of the heart.

A revascularization procedure is often needed in patients who have experienced an artery blockage to help improve blood flow. These procedures are done by inserting a balloon catheter to guide the placement of a tiny metal tube, or stent, that will act as an artificial artery.

Every month, about five million people experience a heart attack. If someone is going to have a heart attack, it will happen within the first hour of the first day of their monthly cycle. The location of the plaque at this time is hard to predict as well as impossible to know for certain what type it is.

The global revascularization devices market is segregated into product types, indications, end-users, and regions. On the basis of product type, the global revascularization devices market is sub-segmented into stents, balloon catheters, and other product types.

With respect to indication, the global revascularization devices market is distributed into large artery atherosclerosis, cardio-embolism, a stroke of other determined etiology, a stroke of undetermined etiology, and other indications.

On the basis of end-user, the global revascularization devices market is sub-segmented into hospitals, ambulatory surgical centers, and specialty clinics.

On the basis of region, the global revascularization devices market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Technological advancements and ongoing research and development activities to bring upgraded devices

Rapid technological advancement in the field of Revascularization Devices, as well as ongoing research and development activities, have revolutionized the way medicine is practiced today.

In addition to a variety of other treatment options available for heart disease patients, a new device has been approved by the FDA for use in coronary artery bypass surgery that significantly reduces complications from surgery and speeds recovery procedures.

The devices are successfully used to restore blood flow to blocked or narrowed arteries.

Multiple advantages to patients and physicians

Revascularization devices offer multiple benefits to patients with peripheral artery disease (PAD) by improving surgical outcomes and reducing the incidence of postoperative complications.

These surgeries include bypass grafts, which is a procedure in which blood vessels from another part of the body are attached to blood vessels near the blocked area, and angioplasty, or balloon treatment. Each of these procedures can be used to treat one or more blocked arteries.

Rising prevalence of neurovascular diseases and disorders, lifestyle diseases

Neurovascular diseases and disorders are becoming increasingly prevalent as a result of the unhealthy lifestyles many people have adopted.

Lifestyle diseases, such as diabetes and high blood pressure, can accelerate the onset of vascular deterioration by causing the arteries to narrow, impairing blood flow which can lead to pain or numbness in the extremities.

Lack of professionals and physicians to operate revascularization devices

The shortage of expertise in this area, coupled with the lack of physicians willing to operate revascularization devices, is a significant problem in cardiology.

The number of physicians qualified to perform these procedures has dwindled over the last several years, often resulting in people who are not trained or equipped with the knowledge required to adequately care for their patients.

This situation is especially problematic in rural areas where it might be quite difficult to find a doctor competent enough to perform this type of procedure.

Potentially adverse events and complications

Although adverse events and complications of the skin and revascularization devices, such as attack by bacteria, allergic reaction, blood vessel injury, or embolism, can hinder the use of revascularization devices, this restraint is projected to counter the expansion of the global revascularization devices market.

COVID-19 Impact on Neurovascular Devices

Globally, the pandemic of COVID-19 has impacted every aspect of the food industry, including interventional neurology devices. Over a six-month period, there has been a sharp fall in the number of patients visiting hospitals.

During the COVID-19 pandemic, there is a sharp variation in the way neurosurgeons administer neuro-interventional techniques. Patients are choosing to go to the hospital in an attempt to avoid contact with COVID-19 patients and healthcare workers. Hospital admissions have declined in a number of clinical settings, such as stroke, myocardial infarction, and other cancers.

The interventional neurology devices market is anticipated to be affected by the temporary postponement of certain elective procedures, as governments and authorities seek to ensure the availability of resources for patients with COVID-19.

Meanwhile, the lockdowns of manufacturing facilities often lead to supply chain interruptions, which have led to a drastic decrease in the recruitment of patients in clinical trials, which in turn has had a significant impact on the growth of the neurovascular devices market in 2020.

Revascularization Devices Market Regional Analysis

On the basis of region, the global revascularization devices market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Markets in North America are expected to account for the largest share of the global market owing to the increasing prevalence of neurovascular diseases in this region, and the growing geriatric population of this region.

Competitive Landscape 

• Medtronic
• Penumbra
• Johnson and Johnson Services, Inc.
• Rapid Medical Ltd.
• Scanmed
• Medinol
• Stryker
• Boston Scientific Corporation
• Biotronic
• Rapid Medical
• Other Key Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Revascularization Devices Market Segmentation:

Key Segments Covered in Global Revascularization Devices Market by Product Type

• Stents
• Balloon Catheter
• Other Product Types

Key Segments Covered in Global Revascularization Devices Market by Indication

• Large artery atherosclerosis
• Cardio-Embolism
• Stroke of other determined Etiology
• Stroke of undetermined Etiology
• Other Indications

Key Segments Covered in Global Revascularization Devices Market by End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics